Beam Therapeutics ↗
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Beam Therapeutics
Revenue$378M▲ 520.0% YoYFY 2023
Operating income−$176M▲ 47.9% YoY
Net profit−$133M▲ 54.2% YoY
Shareholders' equity$981M
Market cap$2.5BBEAM · $24.56
Competitors10identified
About Beam Therapeutics
Sectors
Company details
- Website
- beamtx.com
- Founded
- 2020
- Listed
- Nasdaq: BEAM (since 2020)
Operational Areas of Beam Therapeutics
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameBeam Therapeutics Inc.
TickerBEAM
ExchangeNasdaq
CountryUnited States
SEC CIK0001745999
Listed since2020
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://www.beamtx.com
US market & SEC filings
BEAM · Nasdaq · SEC CIK 0001745999
Last price · 24 Oct 2026
$24.56
−1.13%
Market cap$2.5B
P/E—On FY 2023 diluted EPS
Volume1,384,842
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 2020
BEAM share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Websitehttps://www.beamtx.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Beam Therapeutics
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States | |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.